Dihydrorifampicin, a new specific inhibitor of RNA biosynthesis in eukaryotic cells; reversible cytostatic effect on the growth of human tumour cells and embryonic cells in culture.
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D004247:DNA / Q000096:biosynthesis; D004273:DNA, Neoplasm / Q000096:biosynthesis; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D005347:Fibroblasts / Q000187:drug effects; D009374:Neoplasms, Experimental; D012313:RNA / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012293:Rifampin / Q000031:analogs & derivatives* / Q000494:pharmacology
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D012313:RNA; D004247:DNA; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin